Oneness Biotech Co Ltd (4743) — Capital Reinvestment Ratio

Latest as of September 2025: 0.41x

Oneness Biotech Co Ltd (4743) has a Capital Reinvestment Ratio of 0.41x as of September 2025, meaning it reinvests 0% of its operating cash flow (NT$14.32 Million) in capital expenditures (NT$5.92 Million). Check Oneness Biotech Co Ltd tangible book value ratio to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.41x
Capex / Operating Cash Flow

Operating Cash Flow

NT$14.32 Million
TWD

Capital Expenditures

NT$5.92 Million
TWD

Data as of

Sep 2025
Most recent filing

Oneness Biotech Co Ltd Capital Reinvestment Ratio (2010–2020)

This chart tracks Oneness Biotech Co Ltd's Capital Reinvestment Ratio across 3 annual periods. For the full cash flow conversion analysis, see 4743 cash flow metrics.

Annual Capital Reinvestment Ratio for Oneness Biotech Co Ltd (2010–2020)

Year-by-year Capital Reinvestment Ratio for Oneness Biotech Co Ltd from 2010 to 2020. See 4743 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (TWD) Capital Expenditures YoY Change
2020 0.97x NT$158.14 Million NT$153.27 Million ▲ +151.7%
2012 0.39x NT$24.15 Million NT$9.30 Million ▲ +286.2%
2010 0.10x NT$153.25 Million NT$15.28 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow